MedTrace Logo

Pilot Study to Evaluate Immunopotentiating Effects of Immulina in Elderly Individuals

NCT01784692 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2016-05-26

No results posted yet for this study

Summary

This will be a small study aimed at determining the effects of oral Immulina consumption on the immune system in elderly individuals.

Conditions

  • Elderly Immune Senescence

Interventions

DIETARY_SUPPLEMENT

Immulina

Sponsors & Collaborators

  • University of Mississippi Medical Center

    lead OTHER

Principal Investigators

  • Gailen D. Marshall, Jr., MD, PhD · University of Mississippi Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01784692 on ClinicalTrials.gov